Clincosm LogoSign in Get a demo

monoclonal gammopathy

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Monoclonal Gammopathy Trial in New York, Philadelphia (Isatuximab)

Recruiting
  • Monoclonal Gammopathy
  • Boston, Massachusetts
  • +1 more
Nov 16, 2022

Monoclonal Gammopathy, Smoldering Myeloma, Myeloma Trial in Cleveland (DKK1)

Not yet recruiting
  • Monoclonal Gammopathy
  • +2 more
  • DKK1
  • Cleveland, Ohio
  • +1 more
Nov 29, 2021

Monoclonal Gammopathy, Smoldering Multiple Myeloma Trial in United States (Daratumumab)

Active, not recruiting
  • Monoclonal Gammopathy
  • Smoldering Multiple Myeloma
  • Monterey, California
  • +5 more
Nov 1, 2021

IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)

Recruiting
  • IgA Monoclonal Gammopathy
  • +8 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Oct 18, 2021

Pruritus in Patients With Monoclonal Gammopathy

Completed
  • Pruritus
  • Monoclonal Gammopathy
    • Brest, France
      CHRU de Brest
    Aug 25, 2020

    A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early

    Completed
    • Plasma Cell Dyscrasia
    • Monoclonal Gammopathy
      • Boston, Massachusetts
        Tufts Medical Center
      May 7, 2020

      Monoclonal Gammopathy, Monoclonal Gammopathy of Undetermined Signification, Myeloma Trial in Rennes (blood and bone marrow

      Completed
      • Monoclonal Gammopathy
      • +2 more
      • blood and bone marrow samples
      • Rennes, Bretagne, France
        Rennes University Hospital
      Jan 3, 2014

      Monoclonal Immunoglobulins in Patient With Tuberculosis

      Unknown status
      • Monoclonal Gammopathy
      • Tuberculosis
        • Taipei, Taiwan
          Department of Laboratory Medicine, National Taiwan Univeristy Ho
        Sep 12, 2005